title: The use of granulocyte-colony-stimulating factor in volunteer unrelated hemopoietic stem cell donors.
abstract: Granulocyte-colony-stimulating factor (G-CSF) is used for the mobilization of hemopoietic stem cells in healthy donors. It has a number of common side effects such as bone pain, which resolve rapidly after administration is discontinued. Recent publications have raised concern that it might act as a trigger for the development of hematologic malignancy in susceptible individuals, possibly by causing genomic instability, but to date there is no evidence that healthy volunteer donors who receive G-CSF are at any increased risk. Ongoing studies aim to confirm whether or not G-CSF can cause chromosomal abnormalities in healthy donors. In the UK, the British Bone Marrow Registry and Anthony Nolan Trust give G-CSF to donors who have agreed to donate peripheral blood stem cells. It is recommended by the UK Registries at present that all stem cell donors are given updated information explaining the current uncertainties with regard to the use of G-CSF before they give informed consent to its administration. This information is based on a statement agreed by the World Marrow Donor Association for use by individual donor registries. Further, it is our current practice that all donors who have received G-CSF, as well as marrow donors who do not, should be under regular review for at least 10 years to allow the occurrence of any long-term adverse events to be documented.
authors: The British Bone Marrow Registry and Institute for Transfusion Sciences, Bristol, UK. derwood.pamphilon@nhsbt.nhs.uk
authors: Derwood
authors: D
authors: Pamphilon
authors: Elisabeth
authors: E
authors: Nacheva
authors: Cristina
authors: C
authors: Navarrete
authors: Alejandro
authors: A
authors: Madrigal
authors: John
authors: J
authors: Goldman
mesh_terms: D001782:Blood Donors; D001842:Bone and Bones / Q000187:drug effects / Q000503:physiopathology; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage / Q000009:adverse effects*; D006261:Headache / Q000139:chemically induced; D019650:Hematopoietic Stem Cell Mobilization; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D009325:Nausea / Q000139:chemically induced; D010146:Pain / Q000139:chemically induced; D012042:Registries / Q000706:statistics & numerical data; D006113:United Kingdom; D014839:Vomiting / Q000139:chemically induced
chemical_list: D016179:Granulocyte Colony-Stimulating Factor